Label Changes for:
Zytiga (Abiraterone Acetate) Tablets
Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- Zytiga can cause fetal harm when administered to a pregnant woman. Zytiga is not indicated for use in women…